Search Results for: Pulmonary

5304 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ANK1 and HSPB1 ankyrin 1 heat shock protein family B (small) member 1
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • NrCAM interactions
  • CHL1 interactions
  • Neurofascin interactions
  • Neurofascin interactions
  • COPI-mediated anterograde transport
  • VEGFA-VEGFR2 Pathway
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • MAPK6/MAPK4 signaling
  • Extra-nuclear estrogen signaling
  • Apatorsen
  • Phenethyl Isothiocyanate
  • Hereditary spherocytosis (SPH)
  • Distal hereditary motor neuropathies (dHMN)
ANK1 and RHAG ankyrin 1 Rh associated glycoprotein
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • NrCAM interactions
  • CHL1 interactions
  • Neurofascin interactions
  • Neurofascin interactions
  • COPI-mediated anterograde transport
  • Erythrocytes take up carbon dioxide and release oxygen
  • Erythrocytes take up oxygen and release carbon dioxide
  • Rhesus glycoproteins mediate ammonium transport.
  • Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)
  • Hereditary spherocytosis (SPH)
  • Hereditary stomatocytosis (HSt); Dehydrated hereditary stomatocytosis (DHS); Overhydrated hereditary stomatocytosis (OHS); Familial pseudohyperkalemia (FP)
ANK1 and EPB42 ankyrin 1 erythrocyte membrane protein band 4.2
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • NrCAM interactions
  • CHL1 interactions
  • Neurofascin interactions
  • Neurofascin interactions
  • COPI-mediated anterograde transport
  • Hereditary spherocytosis (SPH)
ANK1 and SLC4A1 ankyrin 1 solute carrier family 4 member 1 (Diego blood group)
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • NrCAM interactions
  • CHL1 interactions
  • Neurofascin interactions
  • Neurofascin interactions
  • COPI-mediated anterograde transport
  • Erythrocytes take up carbon dioxide and release oxygen
  • Erythrocytes take up oxygen and release carbon dioxide
  • Bicarbonate transporters
  • Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)
  • Hereditary spherocytosis (SPH)
  • Hereditary elliptocytosis (HE)
  • Hereditary spherocytosis (SPH)
  • Hereditary stomatocytosis (HSt); Dehydrated hereditary stomatocytosis (DHS); Overhydrated hereditary stomatocytosis (OHS); Familial pseudohyperkalemia (FP)
  • Distal renal tubular acidosis (RTA type 1)
SLC25A6 and PRSS23 solute carrier family 25 member 6 serine protease 23
  • Mitochondrial protein import
  • Mitochondrial protein import
  • Influenza Virus Induced Apoptosis
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Post-translational protein phosphorylation
  • Clodronic Acid
ANXA1 and TRPM7 annexin A1 transient receptor potential cation channel subfamily M member 7
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • Smooth Muscle Contraction
  • Interleukin-4 and Interleukin-13 signaling
  • TRP channels
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 1,4-Dithiothreitol
ANXA2 and TERT annexin A2 telomerase reverse transcriptase
  • Smooth Muscle Contraction
  • Neutrophil degranulation
  • Dissolution of Fibrin Clot
  • Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
  • Telomere Extension By Telomerase
  • Formation of the beta-catenin:TCF transactivating complex
  • Tenecteplase
  • Artenimol
  • Zidovudine
  • Grn163l
  • Tertomotide
  • Cri du chat syndrome; Cat cry syndrome; Chromosme 5p deletion syndrome
ANXA5 and FDFT1 annexin A5 farnesyl-diphosphate farnesyltransferase 1
  • Platelet degranulation
  • Cholesterol biosynthesis
  • PPARA activates gene expression
  • Activation of gene expression by SREBF (SREBP)
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • TAK-475
ANXA5 and EED annexin A5 embryonic ectoderm development
  • Platelet degranulation
  • PRC2 methylates histones and DNA
  • Oxidative Stress Induced Senescence
  • PKMTs methylate histone lysines
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Transcriptional Regulation by E2F6
  • HCMV Early Events
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and LAMC3 annexin A5 laminin subunit gamma 3
  • Platelet degranulation
  • Laminin interactions
  • Laminin interactions
  • Non-integrin membrane-ECM interactions
  • MET activates PTK2 signaling
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and ITGB5 annexin A5 integrin subunit beta 5
  • Platelet degranulation
  • Cross-presentation of particulate exogenous antigens (phagosomes)
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Syndecan interactions
  • Syndecan interactions
  • ECM proteoglycans
  • Smooth Muscle Contraction
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and TERF2IP annexin A5 TERF2 interacting protein
  • Platelet degranulation
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Telomere Extension By Telomerase
  • DNA Damage/Telomere Stress Induced Senescence
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and TINF2 annexin A5 TERF1 interacting nuclear factor 2
  • Platelet degranulation
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Telomere Extension By Telomerase
  • DNA Damage/Telomere Stress Induced Senescence
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • Revesz syndrome; Exudative retinopathy with bone marrow failure
ANXA5 and SUPT4H1 annexin A5 SPT4 homolog, DSIF elongation factor subunit
  • Platelet degranulation
  • Formation of RNA Pol II elongation complex
  • Formation of the Early Elongation Complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of the HIV-1 Early Elongation Complex
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Transcription Elongation
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and KDR annexin A5 kinase insert domain receptor
  • Platelet degranulation
  • Neurophilin interactions with VEGF and VEGFR
  • VEGF binds to VEGFR leading to receptor dimerization
  • Integrin cell surface interactions
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
  • VEGFR2 mediated cell proliferation
  • Signaling by membrane-tethered fusions of PDGFRA or PDGFRB
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • Sorafenib
  • Sunitinib
  • N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA
  • Cediranib
  • Vatalanib
  • XL999
  • TG-100801
  • XL820
  • CYC116
  • Ramucirumab
  • ABT-869
  • IMC-1C11
  • Semaxanib
  • Pazopanib
  • Midostaurin
  • Axitinib
  • 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
  • N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide
  • N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide
  • 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide
  • N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE
  • N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE
  • 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one
  • 3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one
  • N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide
  • N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
  • N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine
  • Cabozantinib
  • Regorafenib
  • Ponatinib
  • Lenvatinib
  • Nintedanib
  • Foretinib
ANXA5 and COL2A1 annexin A5 collagen type II alpha 1 chain
  • Platelet degranulation
  • Collagen degradation
  • Collagen degradation
  • Extracellular matrix organization
  • Collagen biosynthesis and modifying enzymes
  • Signaling by PDGF
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Assembly of collagen fibrils and other multimeric structures
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • Non-integrin membrane-ECM interactions
  • ECM proteoglycans
  • ECM proteoglycans
  • NCAM1 interactions
  • MET activates PTK2 signaling
  • Collagen chain trimerization
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • Collagenase clostridium histolyticum
  • Type II collagenopathies, including: Achondrogenesis II; Hypochondrogenesis; SED congenita; SMED Strudwick type; Kniest dysplasia; Spondyloperipheral dysplasia; Osteoarthritis with mild chondrodysplasia; Stickler syndrome 1; Platyspondylic skeletal dysplasia, Torrance type; Epiphyseal dysplasia, multiple, with myopia and deafness; Czech dysplasia
  • Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
  • Osteoarthritis with mild chondrodysplasia
ANXA5 and COL10A1 annexin A5 collagen type X alpha 1 chain
  • Platelet degranulation
  • Collagen degradation
  • Collagen degradation
  • Collagen biosynthesis and modifying enzymes
  • Assembly of collagen fibrils and other multimeric structures
  • Integrin cell surface interactions
  • Non-integrin membrane-ECM interactions
  • Collagen chain trimerization
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
ANXA5 and APP annexin A5 amyloid beta precursor protein
  • Platelet degranulation
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Phenserine
  • Tiomolibdate ion
  • CAD106
  • Mito-4509
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Alzheimer's disease (AD)
ANXA5 and TERF1 annexin A5 telomeric repeat binding factor 1
  • Platelet degranulation
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Telomere Extension By Telomerase
  • DNA Damage/Telomere Stress Induced Senescence
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper
ANXA5 and TERF2 annexin A5 telomeric repeat binding factor 2
  • Platelet degranulation
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Telomere Extension By Telomerase
  • DNA Damage/Telomere Stress Induced Senescence
  • L-Alpha-Glycerophosphorylserine
  • L-thioproline
  • K201
  • L-Alpha-Glycerophosphorylethanolamine
  • 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid
  • N,O6-Disulfo-Glucosamine
  • 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid
  • Copper

Page 23 out of 266 pages